questionsmedicales.fr
Environnement et santé publique
Environnement
Mouvements de l'eau
Mouvements de l'eau : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mouvements de l'eau : Questions médicales les plus fréquentes",
"headline": "Mouvements de l'eau : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mouvements de l'eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mouvements de l'eau"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Environnement",
"url": "https://questionsmedicales.fr/mesh/D004777",
"about": {
"@type": "MedicalCondition",
"name": "Environnement",
"code": {
"@type": "MedicalCode",
"code": "D004777",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.230"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Mouvements de l'eau",
"alternateName": "Water Movements",
"code": {
"@type": "MedicalCode",
"code": "D014872",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ryan S Wagner",
"url": "https://questionsmedicales.fr/author/Ryan%20S%20Wagner",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, Bowling Green State University, Bowling Green, OH, United States."
}
},
{
"@type": "Person",
"name": "Katelyn M McKindles",
"url": "https://questionsmedicales.fr/author/Katelyn%20M%20McKindles",
"affiliation": {
"@type": "Organization",
"name": "Great Lakes Center for Fresh Waters and Human Health, Bowling Green State University, Bowling Green, OH, United States."
}
},
{
"@type": "Person",
"name": "George S Bullerjahn",
"url": "https://questionsmedicales.fr/author/George%20S%20Bullerjahn",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, Bowling Green State University, Bowling Green, OH, United States."
}
},
{
"@type": "Person",
"name": "Miguel A Gonzalez",
"url": "https://questionsmedicales.fr/author/Miguel%20A%20Gonzalez",
"affiliation": {
"@type": "Organization",
"name": "Universidad Rey Juan Carlos, ESCET, Mostoles, 28933 Madrid, Spain."
}
},
{
"@type": "Person",
"name": "Alberto Zaragoza",
"url": "https://questionsmedicales.fr/author/Alberto%20Zaragoza",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, The University of Utah, Salt Lake City, Utah 84112-0850, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cyclization of Peptides Enhances the Inhibitory Activity against Ganglioside-Induced Aβ Fibril Formation.",
"datePublished": "2023-11-16",
"url": "https://questionsmedicales.fr/article/37971427",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acschemneuro.3c00589"
}
},
{
"@type": "ScholarlyArticle",
"name": "Binding of Cholera Toxin B-Subunit to a Ganglioside GM1-Functionalized PEG-Tethered Lipid Membrane.",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/35604017",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.langmuir.2c00499"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regulation of signal transduction by gangliosides in lipid rafts: focus on GM3-IR and GM1-TrkA interactions.",
"datePublished": "2022-11-11",
"url": "https://questionsmedicales.fr/article/36331354",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/1873-3468.14532"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pharmacokinetics, safety, and efficacy of GM1 ganglioside in healthy subjects and patients with multiple myeloma: Two dose-escalation studies.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37586437",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejps.2023.106565"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison and Possible Binding Orientations of SARS-CoV-2 Spike N-Terminal Domain for Gangliosides GM3 and GM1.",
"datePublished": "2023-07-31",
"url": "https://questionsmedicales.fr/article/37523476",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.jpcb.3c02286"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Environnement",
"item": "https://questionsmedicales.fr/mesh/D004777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mouvements de l'eau",
"item": "https://questionsmedicales.fr/mesh/D014872"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mouvements de l'eau - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mouvements de l'eau",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mouvements de l'eau",
"description": "Comment diagnostiquer une déshydratation ?\nQuels tests pour évaluer l'équilibre hydrique ?\nQuels signes indiquent une surcharge hydrique ?\nComment détecter un déséquilibre électrolytique ?\nQuels symptômes nécessitent un diagnostic urgent ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=G(M1)+Ganglioside&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mouvements de l'eau",
"description": "Quels sont les symptômes de la déshydratation ?\nComment reconnaître une surcharge hydrique ?\nQuels signes indiquent un déséquilibre hydrique ?\nQuels symptômes sont liés à l'hyperhydratation ?\nQuels symptômes d'un choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=G(M1)+Ganglioside&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mouvements de l'eau",
"description": "Comment prévenir la déshydratation ?\nQuelles mesures pour éviter la surcharge hydrique ?\nComment maintenir un bon équilibre hydrique ?\nQuelles précautions pour les athlètes ?\nComment prévenir les déséquilibres électrolytiques ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=G(M1)+Ganglioside&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mouvements de l'eau",
"description": "Comment traiter la déshydratation légère ?\nQuel traitement pour la surcharge hydrique ?\nComment gérer un déséquilibre électrolytique ?\nQuel est le traitement de l'hyperhydratation ?\nComment traiter un choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=G(M1)+Ganglioside&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mouvements de l'eau",
"description": "Quelles complications de la déshydratation sévère ?\nQuels risques d'une surcharge hydrique prolongée ?\nQuelles complications d'un déséquilibre électrolytique ?\nQuels dangers de l'hyperhydratation ?\nQuelles complications du choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=G(M1)+Ganglioside&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mouvements de l'eau",
"description": "Quels facteurs augmentent le risque de déshydratation ?\nQui est à risque de surcharge hydrique ?\nQuels médicaments augmentent le risque d'un déséquilibre électrolytique ?\nQuels comportements augmentent le risque d'hyperhydratation ?\nQuels facteurs de risque pour le choc hypovolémique ?",
"url": "https://questionsmedicales.fr/mesh/D014872?mesh_terms=G(M1)+Ganglioside&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déshydratation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par l'évaluation des symptômes cliniques et des tests sanguins."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'équilibre hydrique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins, urinaires et des mesures de poids peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surcharge hydrique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent œdème, hypertension et dyspnée."
}
},
{
"@type": "Question",
"name": "Comment détecter un déséquilibre électrolytique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des analyses sanguines mesurant les niveaux de sodium et potassium."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un diagnostic urgent ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Confusion, convulsions ou perte de conscience doivent être évalués rapidement."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la déshydratation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Soif intense, sécheresse de la peau, fatigue et urine foncée."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une surcharge hydrique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes incluent gonflement des membres, essoufflement et prise de poids rapide."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un déséquilibre hydrique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, crampes musculaires et troubles de la concentration."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'hyperhydratation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, maux de tête et confusion mentale peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'un choc hypovolémique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pulsations rapides, peau froide et confusion mentale sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déshydratation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Boire régulièrement de l'eau, surtout par temps chaud ou lors d'exercices."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter la surcharge hydrique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Limiter l'apport en liquides et surveiller les signes d'œdème."
}
},
{
"@type": "Question",
"name": "Comment maintenir un bon équilibre hydrique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consommer des aliments riches en eau et surveiller l'apport en électrolytes."
}
},
{
"@type": "Question",
"name": "Quelles précautions pour les athlètes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "S'hydrater avant, pendant et après l'exercice pour éviter la déshydratation."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déséquilibres électrolytiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Avoir une alimentation équilibrée et surveiller les niveaux lors de maladies."
}
},
{
"@type": "Question",
"name": "Comment traiter la déshydratation légère ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation orale avec des solutions électrolytiques est recommandée."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la surcharge hydrique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Restriction hydrique et diurétiques peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "Comment gérer un déséquilibre électrolytique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments ou des modifications alimentaires peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de l'hyperhydratation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réduction de l'apport hydrique et administration de diurétiques."
}
},
{
"@type": "Question",
"name": "Comment traiter un choc hypovolémique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Administration rapide de fluides intraveineux et traitement de la cause sous-jacente."
}
},
{
"@type": "Question",
"name": "Quelles complications de la déshydratation sévère ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des lésions rénales, des convulsions et un choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Quels risques d'une surcharge hydrique prolongée ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut causer un œdème pulmonaire et des troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Quelles complications d'un déséquilibre électrolytique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des arythmies cardiaques et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels dangers de l'hyperhydratation ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut provoquer un œdème cérébral et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Quelles complications du choc hypovolémique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner une défaillance multi-organique et un décès si non traité."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de déshydratation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, maladies chroniques et climat chaud sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque de surcharge hydrique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes avec insuffisance cardiaque ou rénale sont particulièrement à risque."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque d'un déséquilibre électrolytique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les diurétiques et certains laxatifs peuvent provoquer des déséquilibres."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'hyperhydratation ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive de liquides sans équilibre électrolytique peut être risquée."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le choc hypovolémique ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Traumatismes, hémorragies et déshydratation sévère augmentent le risque."
}
}
]
}
]
}
Alzheimer's disease is a progressive neurodegenerative disease and is the most common cause of dementia. It has been reported that the assembly of amyloid β-protein (Aβ) on the cell membrane is induce...
We report neutron reflectometry (NR) studies of polyethylene glycol (PEG)-tethered model lipid membranes at the solid-liquid interface and of cholera toxin's B-subunit (CTxB) binding to tethered membr...
The interactions between gangliosides and proteins belonging to the same or different lipid domains and their influence on physiological and pathological states have been analysed in detail. A well-kn...
This study aimed to assess the pharmacokinetics, safety, and efficacy of GM1 in healthy Chinese subjects and patients with multiple myeloma....
The data used in this study was derived from two dose-escalation trials: GM1-101, involving 70 healthy subjects, and GM1-201, which included 160 multiple myeloma patients. Population pharmacokinetics ...
A one-compartment model with first-order elimination best characterized the pharmacokinetics of GM1. The clearance and volume of distribution, as estimated by the final model, were 0.0942 L/h and 3.27...
This study provides the first population pharmacokinetic analysis of GM1. GM1 exhibits a favorable safety profile among healthy subjects and patients with multiple myeloma. GM1 proved effective in mit...
ChiCTR2000041283 and ChiCTR2000041283....
SARS-CoV-2 spike glycoprotein is anchored by gangliosides. The sialic acid in the ganglioside headgroup is responsible for virus attachment and entry into host cells. We used coarse-grained (CG) molec...
Lipid binding kinetics and energetics of self-aggregated and disordered beta-amyloid oligomers of various sizes, from solution to lipid raft surfaces, were investigated using MD simulations. Our syste...
Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting millions of patients worldwide. Many therapeutics are available for treating PD symptoms but there is no disease-modifyin...
Alterations in glycosphingolipid metabolism have been linked to the pathophysiological mechanisms of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease affecting motor neurons. According...
Autism spectrum disorders (ASD) are devastating neurodevelopmental disorders that showed global increased prevalence. They are characterized by impairment of social communication and stereotyped patte...
This study aimed at measuring the levels of total sialic acid (SA) and anti-ganglioside M1 (anti- GM1) IgG antibodies as essential biomarkers in a cohort of children with ASD to identify their diagnos...
The demographic characteristics, anthropometric measurements, and clinical data were recorded. The levels of total plasma SA and serum anti-GM1 IgG antibodies levels were measured in 100 children with...
Children with ASD had significantly higher levels of both SA and anti-GM1 antibodies than healthy controls (p < 0.001). SA showed a statistically significant moderate diagnostic performance while anti...
The significantly increased levels of SA and anti-GM1 antibodies in children with ASD and their correlation with autism-related symptoms suggest their possible etiopathogenic role in autism as one of ...
The structure of a sialoglycan can be translated into to a biological response when it binds to a specific endogenous lectin. Among endogenous sialic acid-binding lectins in humans are those comprisin...